188 related articles for article (PubMed ID: 27336788)
1. Comparative Characterization of Shiga Toxin Type 2 and Subtilase Cytotoxin Effects on Human Renal Epithelial and Endothelial Cells Grown in Monolayer and Bilayer Conditions.
Álvarez RS; Sacerdoti F; Jancic C; Paton AW; Paton JC; Ibarra C; Amaral MM
PLoS One; 2016; 11(6):e0158180. PubMed ID: 27336788
[TBL] [Abstract][Full Text] [Related]
2. Cytoprotective effect of curcumin in human proximal tubule epithelial cells exposed to shiga toxin.
Sood A; Mathew R; Trachtman H
Biochem Biophys Res Commun; 2001 Apr; 283(1):36-41. PubMed ID: 11322764
[TBL] [Abstract][Full Text] [Related]
3. Differential response of the human renal proximal tubular epithelial cell line HK-2 to Shiga toxin types 1 and 2.
Lentz EK; Leyva-Illades D; Lee MS; Cherla RP; Tesh VL
Infect Immun; 2011 Sep; 79(9):3527-40. PubMed ID: 21708996
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of water absorption in human proximal tubular epithelial cells in response to Shiga toxin-2.
Silberstein C; Pistone Creydt V; Gerhardt E; Núñez P; Ibarra C
Pediatr Nephrol; 2008 Nov; 23(11):1981-90. PubMed ID: 18607643
[TBL] [Abstract][Full Text] [Related]
5. [Cytotoxic effect of Shiga toxin type 2 and its B subunit on human renal tubular epithelial cell cultures].
Creydt VP; Nuñez P; Zotta E; Ibarra C
Medicina (B Aires); 2005; 65(2):147-50. PubMed ID: 16075810
[TBL] [Abstract][Full Text] [Related]
6. Human Recombinant Fab Fragment Neutralizes Shiga Toxin Type 2 Cytotoxic Effects
Luz D; Amaral MM; Sacerdoti F; Bernal AM; Quintilio W; Moro AM; Palermo MS; Ibarra C; Piazza RMF
Toxins (Basel); 2018 Dec; 10(12):. PubMed ID: 30513821
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic effect of Shiga toxin-2 holotoxin and its B subunit on human renal tubular epithelial cells.
Creydt VP; Silberstein C; Zotta E; Ibarra C
Microbes Infect; 2006 Feb; 8(2):410-9. PubMed ID: 16242986
[TBL] [Abstract][Full Text] [Related]
8. A dietary non-human sialic acid may facilitate hemolytic-uremic syndrome.
Löfling JC; Paton AW; Varki NM; Paton JC; Varki A
Kidney Int; 2009 Jul; 76(2):140-4. PubMed ID: 19387473
[TBL] [Abstract][Full Text] [Related]
9. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.
Morigi M; Galbusera M; Gastoldi S; Locatelli M; Buelli S; Pezzotta A; Pagani C; Noris M; Gobbi M; Stravalaci M; Rottoli D; Tedesco F; Remuzzi G; Zoja C
J Immunol; 2011 Jul; 187(1):172-80. PubMed ID: 21642543
[TBL] [Abstract][Full Text] [Related]
10. A clinical and bacteriological study of children suffering from haemolytic uraemic syndrome in Tucuman, Argentina.
Miceli S; Jure MA; de Saab OA; de Castillo MC; Rojas S; de Holgado AP; de Nader OM
Jpn J Infect Dis; 1999 Apr; 52(2):33-7. PubMed ID: 10816611
[TBL] [Abstract][Full Text] [Related]
11. Fractalkine and CX3CR1 mediate leukocyte capture by endothelium in response to Shiga toxin.
Zanchi C; Zoja C; Morigi M; Valsecchi F; Liu XY; Rottoli D; Locatelli M; Buelli S; Pezzotta A; Mapelli P; Geelen J; Remuzzi G; Hawiger J
J Immunol; 2008 Jul; 181(2):1460-9. PubMed ID: 18606701
[TBL] [Abstract][Full Text] [Related]
12. Cytokine expression in the renal tubular epithelial cells stimulated by Shiga toxin 2 of Escherichia coli O157:H7.
Lee JE; Kim JS; Choi IH; Tagawa M; Kohsaka T; Jin DK
Ren Fail; 2002 Sep; 24(5):567-75. PubMed ID: 12380901
[TBL] [Abstract][Full Text] [Related]
13. Tissue factor–dependent procoagulant activity of subtilase cytotoxin, a potent AB5 toxin produced by shiga toxigenic Escherichia coli.
Wang H; Paton JC; Thorpe CM; Bonder CS; Sun WY; Paton AW
J Infect Dis; 2010 Nov; 202(9):1415-23. PubMed ID: 20874089
[TBL] [Abstract][Full Text] [Related]
14. Characterization and epidemiologic subtyping of Shiga toxin-producing Escherichia coli strains isolated from hemolytic uremic syndrome and diarrhea cases in Argentina.
Rivas M; Miliwebsky E; Chinen I; Roldán CD; Balbi L; García B; Fiorilli G; Sosa-Estani S; Kincaid J; Rangel J; Griffin PM;
Foodborne Pathog Dis; 2006; 3(1):88-96. PubMed ID: 16602984
[TBL] [Abstract][Full Text] [Related]
15. Shiga toxins 1 and 2 translocate differently across polarized intestinal epithelial cells.
Hurley BP; Jacewicz M; Thorpe CM; Lincicome LL; King AJ; Keusch GT; Acheson DW
Infect Immun; 1999 Dec; 67(12):6670-7. PubMed ID: 10569789
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Escherichia coli Isolates from humans, food, and farm and companion animals for presence of Shiga toxin-producing E. coli virulence markers.
Murinda SE; Nguyen LT; Landers TL; Draughon FA; Mathew AG; Hogan JS; Smith KL; Hancock DD; Oliver SP
Foodborne Pathog Dis; 2004; 1(3):178-84. PubMed ID: 15992278
[TBL] [Abstract][Full Text] [Related]
17. Shiga toxin 2 and lipopolysaccharide induce human microvascular endothelial cells to release chemokines and factors that stimulate platelet function.
Guessous F; Marcinkiewicz M; Polanowska-Grabowska R; Kongkhum S; Heatherly D; Obrig T; Gear AR
Infect Immun; 2005 Dec; 73(12):8306-16. PubMed ID: 16299328
[TBL] [Abstract][Full Text] [Related]
18. A new pathogenicity island carrying an allelic variant of the Subtilase cytotoxin is common among Shiga toxin producing Escherichia coli of human and ovine origin.
Michelacci V; Tozzoli R; Caprioli A; Martínez R; Scheutz F; Grande L; Sánchez S; Morabito S
Clin Microbiol Infect; 2013 Mar; 19(3):E149-56. PubMed ID: 23331629
[TBL] [Abstract][Full Text] [Related]
19. Silencing of Bak ameliorates apoptosis of human proximal tubular epithelial cells by Escherichia coli-derived Shiga toxin 2.
Wilson C; Foster GH; Bitzan M
Infection; 2005 Oct; 33(5-6):362-7. PubMed ID: 16258868
[TBL] [Abstract][Full Text] [Related]
20. Production of the subtilase AB5 cytotoxin by Shiga toxin-negative Escherichia coli.
Tozzoli R; Caprioli A; Cappannella S; Michelacci V; Marziano ML; Morabito S
J Clin Microbiol; 2010 Jan; 48(1):178-83. PubMed ID: 19940059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
